February 5, 2015. The 21st Century Cures proposed legislation represents a frightening assault on the agency and the safety of medical products, and the FDA will need a very strong leader to protect its public health mission.
Read More »On Health Policy
NCHR Testimony Before the FDA on “Framework for Regulatory Oversight of Laboratory Developed Tests”
January 8, 2015. Our Center has frequently urged the FDA to improve their oversight of medical devices. Despite past criticisms, we believe it is essential that FDA have the authority to regulate laboratory-developed tests in order to stimulate even better science, and help ensure that patients receive the full benefit of our growing scientific knowledge.
Read More »Letters to Congressional Leadership Supporting the Medical Device Excise Tax
January 9, 2015. This is a sample of the letters that were sent to key Democrats and Republicans in the House and Senate in January 2015.
Read More »NCHR Testimony to FDA on Updating the “Redbook”
December 9, 2014. We enthusiastically welcome further action from the FDA on all substances over which the Center for Food Safety and Applied Nutrition has authority. While the FDA has taken steps to address safety concerns regarding some substances, we strongly urge the agency to use its full authority to ensure the safety of all food-related and consumer products.
Read More »NCHR Testimony at FDA Advisory Committee on Anti-Infective Drugs
December 4, 2014. Antibiotic resistance and the inability to treat common infections is an increasingly urgent public health crisis which affects everyone, especially some of the most vulnerable in our society. Finding treatment options for unmet populations is urgently important but ineffective antibiotics lead to an increase in antibiotic resistance.
Read More »